Immunohistochemistry Market By Product (Antibody, Reagents, Kits, Equipment), By Application (Diagnosis, Research Applications, Forensic), By End User (Hospital and Diagnostic Labs, Research Institutes and Academic Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global immunohistochemistry market was valued at $2,388.5 million in 2021 and is projected to reach $4,530.56 million by 2031, registering a CAGR of 6.5% from 2022 to 2031. Immunohistochemistry is a valuable technique that is used for the identification and visualization of tissue antigens in biological research and clinical diagnostics. In addition, Immunohistochemistry (IHC) is a diagnostic technique that is conducted in a laboratory. It involves performing special tests on your biopsy tissue sample to help diagnose the disease more precisely.
The key factors that drive the growth of the market are an increase in the prevalence of the geriatric population, a rise in the prevalence of chronic disease and a rise in healthcare expenditure boosts the market growth. However, a dearth of skilled professionals restricts the market growth in the forecast period. Moreover, rise in technological advancements in IHC, increase in a number of product approvals and availability of reimbursements for IHC tests offer lucrative opportunities to the market player operating in the immunohistochemistry market.
The global Immunohistochemistry market is segmented into product, application, end-user, and region. By product, the market is categorized into antibodies, reagents, equipment, and kits. the antibody segment is further classified into primary antibodies and secondary antibodies. By reagent segment is further classified into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, organic solvents, proteolytic enzymes, diluents, and other reagents equipment segment is further classified into slide-staining systems, tissue processing systems, slide scanners and other. kits segment is further classified into IHC kits for human tissue, IHC kits for animal tissue. By application, the market is segmented into diagnosis, research applications, and forensics. By diagnosis, the segment is further bifurcated into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. By research, the application segment is further classified into drug testing and others. By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global Immunohistochemistry market are Abcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc, Diagnostic Biosystems Inc., Eagle Biosciences Inc, F. Hoffman-La Roche AG, Genemed Biotechnologies Inc, Merck KGaA, Miltenyi Biotec GmbH, PerkinElmer Inc, Rockland Immunochemicals Inc, Takara Bio. Inc and thermo Fischer Scientific, Inc
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the immunohistochemistry market analysis from 2021 to 2031 to identify the prevailing immunohistochemistry market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the immunohistochemistry market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global immunohistochemistry market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Antibody
Type
Primary Antibodies
Secondary Antibodies
Reagents
Type
Histological Stains
Blocking Sera and Reagents
Chromogenic Substrates
Diluents
Fixation Reagents
Organic Solvents
Proteolytic Enzymes
Other
Kits
Type
IHC Kits for Animal Tissue
IHC Kits for Human Tissue
Equipment
Type
Slide staining Systems
Tissue Processing Systems
Slide Scanners
Others
By Application
Diagnosis
Type
Infectious diseases
Neurological diseases
Nephrological diseases
Autoimmune diseases
Cancer
Others
Research Applications
Type
Drug Testing
Others
Forensic
By End User
Hospital and Diagnostic Labs
Research Institutes and Academic Institutes
Others
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Italy
Spain
Rest of Europe
Germany
France
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Agilent Technologies Inc
Abcam Plc
F hoffman La Roche
Merck Kgaa
Biorad Laboratories
Thermofischer Scientific Inc
Cell Signaling Technology, Inc
Bio SB
Takara Bio, Inc
PHC Holdings Corporation
Miltenyi Biotec
CANDOR Bioscience GmbH
Sakura Finetek Japan Co., Ltd
Eagle Biosciences, Inc.
Biocare Medical, LLC
Elabscience, Inc.
Biogenex Laboratories
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Antibody
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Antibody Immunohistochemistry Market by Type
- 4.3 Reagents
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Reagents Immunohistochemistry Market by Type
- 4.4 Kits
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.4.4 Kits Immunohistochemistry Market by Type
- 4.5 Equipment
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.5.4 Equipment Immunohistochemistry Market by Type
- CHAPTER 5: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Diagnosis
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Diagnosis Immunohistochemistry Market by Type
- 5.3 Research Applications
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.3.4 Research Applications Immunohistochemistry Market by Type
- 5.4 Forensic
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: IMMUNOHISTOCHEMISTRY MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospital and Diagnostic Labs
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Research Institutes and Academic Institutes
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: IMMUNOHISTOCHEMISTRY MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest Of Asia Pacific
- 7.4.5.6.1 Market size and forecast, by Product
- 7.4.5.6.2 Market size and forecast, by Application
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Agilent Technologies Inc
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Abcam Plc
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 F hoffman La Roche
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Merck Kgaa
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Biorad Laboratories
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Thermofischer Scientific Inc
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Cell Signaling Technology, Inc
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Bio SB
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Takara Bio, Inc
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 PHC Holdings Corporation
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 Miltenyi Biotec
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 CANDOR Bioscience GmbH
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Sakura Finetek Japan Co., Ltd
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Eagle Biosciences, Inc.
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Biocare Medical, LLC
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Elabscience, Inc.
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Biogenex Laboratories
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 2. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR ANTIBODY, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. GLOBAL ANTIBODY IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 5. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR REAGENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 6. IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 7. GLOBAL REAGENTS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 8. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR KITS, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 10. GLOBAL KITS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 11. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. GLOBAL EQUIPMENT IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 15. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR DIAGNOSIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSIS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. GLOBAL DIAGNOSIS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 18. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR RESEARCH APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. GLOBAL RESEARCH APPLICATIONS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 21. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR FORENSIC, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 24. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR HOSPITAL AND DIAGNOSTIC LABS, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITAL AND DIAGNOSTIC LABS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR RESEARCH INSTITUTES AND ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH INSTITUTES AND ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. IMMUNOHISTOCHEMISTRY MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 34. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 35. U.S. IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 36. U.S. IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 37. U.S. IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. CANADA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 39. CANADA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 40. CANADA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 41. MEXICO IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 42. MEXICO IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 43. MEXICO IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 44. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 45. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 46. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 47. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 48. GERMANY IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 49. GERMANY IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 50. GERMANY IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 51. FRANCE IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 52. FRANCE IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 53. FRANCE IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 54. UK IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 55. UK IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 56. UK IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 57. ITALY IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 58. ITALY IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 59. ITALY IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 60. SPAIN IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 61. SPAIN IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 62. SPAIN IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 63. REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 64. REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 65. REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 66. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 67. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 68. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 69. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 70. JAPAN IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 71. JAPAN IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 72. JAPAN IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 73. CHINA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 74. CHINA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 75. CHINA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 76. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 77. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 78. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 79. INDIA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 80. INDIA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 81. INDIA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 82. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 83. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 84. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 85. REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 86. REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 87. REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 88. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 89. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 90. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 91. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 92. BRAZIL IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 93. BRAZIL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 94. BRAZIL IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 95. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 96. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 97. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 98. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 99. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 100. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 101. REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 102. REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 103. REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 104.AGILENT TECHNOLOGIES INC: COMPANY SNAPSHOT
- TABLE 105.AGILENT TECHNOLOGIES INC: OPERATING SEGMENTS
- TABLE 106.AGILENT TECHNOLOGIES INC: PRODUCT PORTFOLIO
- TABLE 107.AGILENT TECHNOLOGIES INC: NET SALES,
- TABLE 108.AGILENT TECHNOLOGIES INC: KEY STRATERGIES
- TABLE 109.ABCAM PLC: COMPANY SNAPSHOT
- TABLE 110.ABCAM PLC: OPERATING SEGMENTS
- TABLE 111.ABCAM PLC: PRODUCT PORTFOLIO
- TABLE 112.ABCAM PLC: NET SALES,
- TABLE 113.ABCAM PLC: KEY STRATERGIES
- TABLE 114.F HOFFMAN LA ROCHE: COMPANY SNAPSHOT
- TABLE 115.F HOFFMAN LA ROCHE: OPERATING SEGMENTS
- TABLE 116.F HOFFMAN LA ROCHE: PRODUCT PORTFOLIO
- TABLE 117.F HOFFMAN LA ROCHE: NET SALES,
- TABLE 118.F HOFFMAN LA ROCHE: KEY STRATERGIES
- TABLE 119.MERCK KGAA: COMPANY SNAPSHOT
- TABLE 120.MERCK KGAA: OPERATING SEGMENTS
- TABLE 121.MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 122.MERCK KGAA: NET SALES,
- TABLE 123.MERCK KGAA: KEY STRATERGIES
- TABLE 124.BIORAD LABORATORIES: COMPANY SNAPSHOT
- TABLE 125.BIORAD LABORATORIES: OPERATING SEGMENTS
- TABLE 126.BIORAD LABORATORIES: PRODUCT PORTFOLIO
- TABLE 127.BIORAD LABORATORIES: NET SALES,
- TABLE 128.BIORAD LABORATORIES: KEY STRATERGIES
- TABLE 129.THERMOFISCHER SCIENTIFIC INC: COMPANY SNAPSHOT
- TABLE 130.THERMOFISCHER SCIENTIFIC INC: OPERATING SEGMENTS
- TABLE 131.THERMOFISCHER SCIENTIFIC INC: PRODUCT PORTFOLIO
- TABLE 132.THERMOFISCHER SCIENTIFIC INC: NET SALES,
- TABLE 133.THERMOFISCHER SCIENTIFIC INC: KEY STRATERGIES
- TABLE 134.CELL SIGNALING TECHNOLOGY, INC: COMPANY SNAPSHOT
- TABLE 135.CELL SIGNALING TECHNOLOGY, INC: OPERATING SEGMENTS
- TABLE 136.CELL SIGNALING TECHNOLOGY, INC: PRODUCT PORTFOLIO
- TABLE 137.CELL SIGNALING TECHNOLOGY, INC: NET SALES,
- TABLE 138.CELL SIGNALING TECHNOLOGY, INC: KEY STRATERGIES
- TABLE 139.BIO SB: COMPANY SNAPSHOT
- TABLE 140.BIO SB: OPERATING SEGMENTS
- TABLE 141.BIO SB: PRODUCT PORTFOLIO
- TABLE 142.BIO SB: NET SALES,
- TABLE 143.BIO SB: KEY STRATERGIES
- TABLE 144.TAKARA BIO, INC: COMPANY SNAPSHOT
- TABLE 145.TAKARA BIO, INC: OPERATING SEGMENTS
- TABLE 146.TAKARA BIO, INC: PRODUCT PORTFOLIO
- TABLE 147.TAKARA BIO, INC: NET SALES,
- TABLE 148.TAKARA BIO, INC: KEY STRATERGIES
- TABLE 149.PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT
- TABLE 150.PHC HOLDINGS CORPORATION: OPERATING SEGMENTS
- TABLE 151.PHC HOLDINGS CORPORATION: PRODUCT PORTFOLIO
- TABLE 152.PHC HOLDINGS CORPORATION: NET SALES,
- TABLE 153.PHC HOLDINGS CORPORATION: KEY STRATERGIES
- TABLE 154.MILTENYI BIOTEC: COMPANY SNAPSHOT
- TABLE 155.MILTENYI BIOTEC: OPERATING SEGMENTS
- TABLE 156.MILTENYI BIOTEC: PRODUCT PORTFOLIO
- TABLE 157.MILTENYI BIOTEC: NET SALES,
- TABLE 158.MILTENYI BIOTEC: KEY STRATERGIES
- TABLE 159.CANDOR BIOSCIENCE GMBH: COMPANY SNAPSHOT
- TABLE 160.CANDOR BIOSCIENCE GMBH: OPERATING SEGMENTS
- TABLE 161.CANDOR BIOSCIENCE GMBH: PRODUCT PORTFOLIO
- TABLE 162.CANDOR BIOSCIENCE GMBH: NET SALES,
- TABLE 163.CANDOR BIOSCIENCE GMBH: KEY STRATERGIES
- TABLE 164.SAKURA FINETEK JAPAN CO., LTD: COMPANY SNAPSHOT
- TABLE 165.SAKURA FINETEK JAPAN CO., LTD: OPERATING SEGMENTS
- TABLE 166.SAKURA FINETEK JAPAN CO., LTD: PRODUCT PORTFOLIO
- TABLE 167.SAKURA FINETEK JAPAN CO., LTD: NET SALES,
- TABLE 168.SAKURA FINETEK JAPAN CO., LTD: KEY STRATERGIES
- TABLE 169.EAGLE BIOSCIENCES, INC.: COMPANY SNAPSHOT
- TABLE 170.EAGLE BIOSCIENCES, INC.: OPERATING SEGMENTS
- TABLE 171.EAGLE BIOSCIENCES, INC.: PRODUCT PORTFOLIO
- TABLE 172.EAGLE BIOSCIENCES, INC.: NET SALES,
- TABLE 173.EAGLE BIOSCIENCES, INC.: KEY STRATERGIES
- TABLE 174.BIOCARE MEDICAL, LLC: COMPANY SNAPSHOT
- TABLE 175.BIOCARE MEDICAL, LLC: OPERATING SEGMENTS
- TABLE 176.BIOCARE MEDICAL, LLC: PRODUCT PORTFOLIO
- TABLE 177.BIOCARE MEDICAL, LLC: NET SALES,
- TABLE 178.BIOCARE MEDICAL, LLC: KEY STRATERGIES
- TABLE 179.ELABSCIENCE, INC.: COMPANY SNAPSHOT
- TABLE 180.ELABSCIENCE, INC.: OPERATING SEGMENTS
- TABLE 181.ELABSCIENCE, INC.: PRODUCT PORTFOLIO
- TABLE 182.ELABSCIENCE, INC.: NET SALES,
- TABLE 183.ELABSCIENCE, INC.: KEY STRATERGIES
- TABLE 184.BIOGENEX LABORATORIES: COMPANY SNAPSHOT
- TABLE 185.BIOGENEX LABORATORIES: OPERATING SEGMENTS
- TABLE 186.BIOGENEX LABORATORIES: PRODUCT PORTFOLIO
- TABLE 187.BIOGENEX LABORATORIES: NET SALES,
- TABLE 188.BIOGENEX LABORATORIES: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.IMMUNOHISTOCHEMISTRY MARKET SEGMENTATION
- FIGURE 2.IMMUNOHISTOCHEMISTRY MARKET,2021-2031
- FIGURE 3.IMMUNOHISTOCHEMISTRY MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.IMMUNOHISTOCHEMISTRY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.IMMUNOHISTOCHEMISTRY MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANTIBODY IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF REAGENTS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF KITS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF EQUIPMENT IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 17.IMMUNOHISTOCHEMISTRY MARKET,BY APPLICATION,2021(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIAGNOSIS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF RESEARCH APPLICATIONS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF FORENSIC IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 21.IMMUNOHISTOCHEMISTRY MARKET,BY END USER,2021(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITAL AND DIAGNOSTIC LABS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
- FIGURE 25.IMMUNOHISTOCHEMISTRY MARKET BY REGION,2021
- FIGURE 26.U.S. IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 31.UK IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 35.JAPAN IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 36.CHINA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 37.AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 38.INDIA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 41.BRAZIL IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 42.SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 43.SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 44.REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49.COMPETITIVE DASHBOARD
- FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 51.AGILENT TECHNOLOGIES INC.: NET SALES ,($MILLION)
- FIGURE 52.ABCAM PLC.: NET SALES ,($MILLION)
- FIGURE 53.F HOFFMAN LA ROCHE.: NET SALES ,($MILLION)
- FIGURE 54.MERCK KGAA.: NET SALES ,($MILLION)
- FIGURE 55.BIORAD LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 56.THERMOFISCHER SCIENTIFIC INC.: NET SALES ,($MILLION)
- FIGURE 57.CELL SIGNALING TECHNOLOGY, INC.: NET SALES ,($MILLION)
- FIGURE 58.BIO SB.: NET SALES ,($MILLION)
- FIGURE 59.TAKARA BIO, INC.: NET SALES ,($MILLION)
- FIGURE 60.PHC HOLDINGS CORPORATION.: NET SALES ,($MILLION)
- FIGURE 61.MILTENYI BIOTEC.: NET SALES ,($MILLION)
- FIGURE 62.CANDOR BIOSCIENCE GMBH.: NET SALES ,($MILLION)
- FIGURE 63.SAKURA FINETEK JAPAN CO., LTD.: NET SALES ,($MILLION)
- FIGURE 64.EAGLE BIOSCIENCES, INC..: NET SALES ,($MILLION)
- FIGURE 65.BIOCARE MEDICAL, LLC.: NET SALES ,($MILLION)
- FIGURE 66.ELABSCIENCE, INC..: NET SALES ,($MILLION)
- FIGURE 67.BIOGENEX LABORATORIES.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook